Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2014 | 12-2013 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | N/A | 35,960 |
| Other current assets | 0 | 160 |
| TOTAL | $N/A | $36,120 |
| Non-Current Assets | ||
| Other Non-Current Assets | 0 | 3,920 |
| TOTAL | $N/A | $3,920 |
| Total Assets | $N/A | $40,090 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 1,140 |
| Accrued Expenses | N/A | 9,970 |
| TOTAL | $N/A | $11,110 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $70 |
| Total Liabilities | $N/A | $11,190 |
| Shareholders' Equity | ||
| Shares Outstanding, K | N/A | 77,939 |
| Common Shares | N/A | 1 |
| Retained earnings | N/A | -51,820 |
| Other shareholders' equity | 0 | 72,589 |
| TOTAL | $N/A | $28,900 |
| Total Liabilities And Equity | $0 | $40,090 |